Superiority of Intestinal Adaptation by Hepatocyte Growth Factor in the Jejunum: An Experimental Study in a Short-Bowel Rat Model

In brief

This experimental study investigates recombinant human hepatocyte growth factor (rh-HGF) as a therapeutic agent to enhance intestinal adaptation in a rat model of short bowel syndrome. The research specifically examines HGF's effects on jejunal tissue, offering potential insights for improving intestinal rehabilitation strategies in SBS patients.

Written by the GCMD Library team from the article.